PetMeds Investor ALERT: Block & Leviton Investigating PetMed Express For Securities Fraud; Investors Should Contact the Firm To Potentially Recover Losses
1. Block & Leviton investigates PetMed Express for potential securities violations.
2. PetMed Express delayed financial results due to revenue recognition concerns.
3. CEO and CFO resigned amid financial troubles; stock has dropped nearly 30%.
4. Investors are advised to contact Block & Leviton for potential recovery.
5. Whistleblowers may receive rewards for providing information about PetMed.
The resignation of top executives and pending investigations often signal deeper issues, leading to significant stock price declines. Historically, similar situations within public companies have resulted in stock depreciation, evidenced by firms like Enron or WorldCom.
How important is it?
The article discusses immediate legal and management challenges affecting PetMed, likely leading to investor concern and stock volatility. Given the company's significant stock price drop already, the risk of further declines is notable.
Why Short Term?
Immediate market reactions often occur to news of executive turnover and investigations, typically influencing stock prices in the short term. Investors may react quickly to the unfolding issues, but long-term impacts will depend on management changes and resolutions.
BOSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating PetMed Express, Inc. (NASDAQ:PETS) for potential securities law violations. Investors who have lost money in their PetMed Express investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/pets.
What is this all about?
On June 10, 2025, PetMeds announced that it needed to delay the release of its 2025 fourth quarter and year-end financial results. on July 1, 2025, it revealed a further delay in the filing of its financial results, in part, because of an internal investigation into revenue recognition. On August 12, 2025, PetMeds' CEO and CFO resigned, and the Company's stock price has fallen by almost 30% on this news.
Who is eligible?
Anyone who purchased PetMed Express, Inc. common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What is Block & Leviton doing?
Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.
What should you do next?
If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at shareholders@blockleviton.com, or by phone at (888) 256-2510.
Whistleblower?
If you have non-public information about PetMed Express, Inc., you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at shareholders@blockleviton.com or by phone at (888) 256-2510.
Why should you contact Block & Leviton?
Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website www.blockleviton.com, call (888) 256-2510 or email shareholders@blockleviton.com with any questions.
This notice may constitute attorney advertising.
CONTACT: BLOCK & LEVITON LLP 260 Franklin St., Suite 1860 Boston, MA 02110 Phone: (888) 256-2510 Email: shareholders@blockleviton.com
